Your browser is no longer supported. Please, upgrade your browser.
Settings
NEPT Neptune Wellness Solutions Inc. daily Stock Chart
NEPT [NASD]
Neptune Wellness Solutions Inc.
Index- P/E32.20 EPS (ttm)0.14 Insider Own24.22% Shs Outstand79.24M Perf Week5.34%
Market Cap359.74M Forward P/E- EPS next Y-0.03 Insider Trans0.00% Shs Float55.26M Perf Month18.85%
Income- PEG- EPS next Q-0.02 Inst Own17.42% Short Float6.21% Perf Quarter47.88%
Sales19.76M P/S18.21 EPS this Y- Inst Trans- Short Ratio1.82 Perf Half Y58.74%
Book/sh0.77 P/B5.87 EPS next Y66.70% ROA- Target Price3.15 Perf Year415.91%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range0.82 - 5.14 Perf YTD92.37%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-11.67% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low453.66% ATR0.38
Employees58 Current Ratio- Sales Q/Q-20.90% Oper. Margin- RSI (14)60.35 Volatility7.27% 9.78%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume2.39 Prev Close4.17
ShortableYes LT Debt/Eq- EarningsNov 13 AMC Payout- Avg Volume1.89M Price4.54
Recom2.00 SMA207.06% SMA5019.72% SMA20044.51% Volume4,512,028 Change8.87%
Jan-30-15Resumed ROTH Capital Buy $5
Sep-27-18 08:32AM  Appointment of Caroline Lavoie, Director of Corporate Affairs PR Newswire
08:32AM  Appointment of Caroline Lavoie, Director of Corporate Affairs CNW Group
Sep-20-18 10:30AM  Cannabis and Biotech Stocks Making Investors Bank ACCESSWIRE
07:30AM  Neptune to Present at Sidoti & Company Fall 2018 Conference PR Newswire
07:30AM  Neptune to Present at Sidoti & Company Fall 2018 Conference CNW Group
Sep-19-18 03:52PM  This Marijuana Stock Picked a Good Day to Top the News Cycle Motley Fool +10.30%
07:30AM  Neptune Confirms its Name Change to Neptune Wellness Solutions Inc. PR Newswire
Sep-17-18 04:32PM  Why Bed Bath & Beyond, Frontier Communications, and Neptune Technologies & Bioressources Jumped Today Motley Fool +10.21%
02:42PM  Why This Tiny Marijuana Stock Is Soaring 14% Today Motley Fool
07:00AM  Neptune Receives Confirmation of Readiness Letter from Health Canada PR Newswire
07:00AM  Neptune Receives Confirmation of Readiness Letter from Health Canada CNW Group
Sep-13-18 11:20PM  Massively Undervalued CBD Companies ACCESSWIRE -6.13%
Aug-31-18 02:44PM  Penny Stocks to Watch for September 2018 Investopedia
Aug-16-18 07:30AM  Neptune Announces Appointment of Hélène F. Fortin to its Board of Directors PR Newswire
07:30AM  Neptune Announces Appointment of Hélène F. Fortin to its Board of Directors CNW Group
Aug-15-18 04:16PM  Neptune Announces the Election of its Directors and Voting Results CNW Group +7.86%
06:00AM  Neptune Technologies & Bioressources Inc. to Host Earnings Call ACCESSWIRE
Aug-14-18 06:24PM  Neptune Tech: Fiscal 1Q Earnings Snapshot Associated Press
05:30PM  Neptune Announces First Quarter Results CNW Group
11:45AM  Why Neptune Technologies & Bioressources Incs (TSE:NEPT) Investor Composition Impacts Your Returns Simply Wall St.
Aug-09-18 07:30AM  Neptune Files Two Patent Applications for Innovative Cannabis Extraction Processes PR Newswire
07:30AM  Neptune Files Two Patent Applications for Innovative Cannabis Extraction Processes CNW Group
Aug-07-18 05:42PM  Perceptive Advisors, LLC inceases its position in Neptune Technologies & Bioressources Inc. CNW Group
Jul-31-18 04:00PM  Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2018 PR Newswire
04:00PM  Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2018 CNW Group
Jul-25-18 07:40AM  Breakfast Technical Briefing on Neptune Technologies & Bioressources and Three Other Additional Biotech Stocks ACCESSWIRE +11.70%
Jul-24-18 03:01PM  How to make, and avoid losing, money with marijuana stocks MarketWatch
Jul-20-18 11:18AM  Tilrays IPO is creating a buzz, but dont overspend on marijuana stocks MarketWatch
Jul-12-18 12:54PM  Harry Boxers four health-care stocks to watch MarketWatch +6.81%
Jun-27-18 10:00AM  Investors are making stoner moves by buying marijuana stocks at the wrong time MarketWatch -8.14%
Jun-22-18 02:11PM  Marijuana Stocks: Two to Consider, Two to Avoid InvestorPlace
Jun-20-18 01:26PM  Here's Why Neptune Technologies & Bioressources Rose as Much as 23.8% Today Motley Fool +37.77%
08:00AM  Today's Research Reports on Stocks to Watch: Neptune Technologies & Bioressources and NeuroMetrix ACCESSWIRE
Jun-19-18 07:30AM  Neptune Announces Multi-year Agreement with Canopy Growth to Provide Extracted Cannabis Products CNW Group +31.84%
Jun-15-18 07:55AM  Free Technical Reports on MannKind and Three Additional Biotech Equities ACCESSWIRE +6.97%
Jun-14-18 07:09AM  Wired News - Idera Pharma Announced Phase-2 Trial Results of IMO-8400 in Adult Patients with Dermatomyositis ACCESSWIRE
Jun-05-18 04:48PM  Neptune Announces Fourth Quarter and Year-end Results CNW Group
12:00PM  Neptune Technologies & Bioressources Inc. to Host Earnings Call ACCESSWIRE
May-16-18 01:00PM  Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results Ended March 31, 2018 GlobeNewswire
Apr-30-18 11:20AM  Relevium Announces Agreement with Neptune Wellness for MaxSimil® GlobeNewswire
Feb-14-18 04:00PM  Neptune Announces Third Quarter Results Marketwired
12:30PM  Neptune Technologies & Bioressources Inc. to Host Earnings Call ACCESSWIRE
Feb-12-18 04:24PM  Here's Why Neptune Technologies & Bioressources Inc. Rose as Much as 14% Today Motley Fool +13.71%
08:00AM  Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation Marketwired
Jan-31-18 08:00AM  Neptune to Hold Conference Call to Discuss Third Quarter Results for the Interim Period Ended December 31, 2017 Marketwired +5.30%
Jan-22-18 07:50AM  Wired News Neptune Signs Exclusive Research Agreement for Developing New Medical and Wellness Cannabinoid-Based Products ACCESSWIRE
Jan-19-18 08:00AM  Neptune Announces Research Agreement Aimed at New Medical and Wellness Cannabinoid-based Products Marketwired
Jan-17-18 08:00AM  Neptune makes its recommendations on Bill 157 special consultations at the National Assembly Marketwired
Dec-19-17 05:35AM  [$$] 5 Biotech Stocks a Pro Is Buying Barrons.com
Dec-15-17 03:26PM  Anyone Who Resists the Rise of Legal Cannabis Is Among Dumbest on Wall Street TheStreet.com
Dec-11-17 08:30AM  Strength Sensei Nutraceuticals and Charles R. Poliquin launch MaxSimil® Marketwired +16.07%
Nov-30-17 09:41AM  Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q2, 2018 By the Numbers : November 30, 2017 Capital Cube
08:00AM  Neptune Receives Nasdaq Notification Confirming that it has Regained Compliance with Minimum Bid Requirements Marketwired
Nov-28-17 07:00AM  Highlights of Neptune's Investor Conference Being Held in New York Today Marketwired
Nov-27-17 11:15AM  Neptune Technologies & Bioresources, Inc.: Price momentum supported by strong fundamentals Capital Cube +14.81%
Nov-14-17 04:05PM  Neptune Announces Second Quarter Results Marketwired
Nov-13-17 05:30PM  Acasti Pharma Reports Second Quarter FY 2018 Financial Results Marketwired +9.18%
Nov-07-17 05:00PM  Acasti Pharma Announces Dariush Mozaffarian, M.D., Dr.P.H. Principal Investigator for CaPre Phase 3 Development Program Marketwired
Oct-25-17 09:00AM  Neptune to Hold Business Update Meeting on November 28, 2017 Marketwired
Oct-24-17 11:00AM  Neptune to Hold Conference Call to Discuss Second Quarter Results for the Interim Period Ended September 30, 2017 Marketwired
Oct-04-17 06:39PM  Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures Marketwired
Sep-28-17 07:30AM  Neptune announces appointments for its Cannabis Business Marketwired
Sep-13-17 11:42AM  Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q1, 2018 By the Numbers : September 13, 2017 Capital Cube
Aug-31-17 07:10PM  Acasti Pharma Grants Stock Options Marketwired
Aug-18-17 03:58PM  Neptune Technologies & Bioresources, Inc.: Price momentum supported by strong fundamentals Capital Cube
Aug-17-17 08:00AM  Neptune Announces the Election of its Directors Marketwired +16.88%
Aug-16-17 11:52PM  Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock Option Plan and Other Related Matters Approved at Its AGM Marketwired +6.96%
Aug-15-17 07:15AM  Investor Network: Neptune Technologies & Bioressources Inc. to Host Earnings Call ACCESSWIRE -13.27%
Aug-14-17 05:30PM  Neptune Announces First Quarter Results Marketwired
05:30PM  Acasti Pharma Reports First Quarter FY 2018 Financial Results Marketwired
Aug-08-17 07:10AM  Neptune Announces Resignation of Pierre Fitzgibbon as a Director and the Appointment of John Moretz as Chairman Marketwired
07:05AM  Neptune to Hold Conference Call to Discuss the Transaction with Aker BioMarine Marketwired
07:00AM  Aker BioMarine and Neptune Announce Closing of $US34 Million Transaction to Accelerate Business and Industry Development Marketwired
Jul-28-17 08:15AM  Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures Marketwired
Jul-27-17 09:23AM  Neptune Receives Nasdaq Notification Regarding Minimum Bid Requirements Marketwired
Jul-25-17 10:30AM  Neptune to Hold Conference Call to Discuss First Quarter Results for the Three Months Period Ended June 30, 2017 Marketwired
Jul-05-17 08:15AM  Featured Company News - Opexa Therapeutics and Acer Therapeutics Announced Merger Agreement Followed by Concurrent Financing from Acer Investor Syndicate Accesswire
Jun-16-17 08:00AM  CORRECTION: Acasti Pharma Grants Stock Options Marketwired -12.90%
Jun-14-17 02:22PM  Acasti Pharma Grants Stock Options Marketwired
Jun-12-17 08:00AM  Acasti Pharma To Present at Upcoming International Industry Conferences Marketwired
Jun-07-17 04:11PM  Neptune Announces 4-Month Period and 13-Month Period Results Marketwired
04:05PM  Neptune Announces 4-Month Period and 13-Month Period Results Marketwired
03:00PM  Investor Network: Neptune Technologies & Bioressources Inc. to Host Earnings Call Accesswire
Jun-06-17 04:30PM  Acasti Pharma Reports Fourth Quarter and Full-Year 2017 Financial Results Marketwired
May-18-17 08:30AM  Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results for the Thirteen Months Period Ended March 31, 2017 Marketwired
08:00AM  Acasti Pharma Presents CaPre Clinical Data at National Lipid Association Scientific Sessions Marketwired
May-16-17 08:00AM  Unique Medical Cannabis Partnership Announced, Creating Scientific and Business Development Hub in Sherbrooke, Quebec Marketwired +8.00%
Apr-24-17 08:00AM  Acasti Granted Additional Composition & Use Patents in Taiwan and Australia; Safeguards Valuable Market Expansion Opportunities Marketwired
Apr-12-17 08:00AM  Acasti Pharma to Present CaPre Omega-3 Bridging Study Results at National Lipid Association Scientific Sessions Marketwired
Apr-05-17 05:00PM  Neptune enters into Commercial Distribution Joint Venture in China with Shanghai Chonghe Marine Industry Co., Ltd. Marketwired
Apr-03-17 08:15AM  Neptune and Enzymotec Reach Patent Agreement Ending All Litigation GlobeNewswire
08:00AM  Neptune and Enzymotec reach Patent Agreement Ending All Litigation Marketwired
Mar-08-17 08:00AM  Acasti Pharma Forms Scientific Advisory Board and Appoints Two Leading Cardiovascular Disease Experts Marketwired
Feb-24-17 12:33PM  Acasti Pharma Grants Incentive Stock and Options Marketwired
Feb-22-17 01:54PM  Neptune to Present at ROTH Capital Partners 29th Annual Growth Stock Conference Marketwired +5.87%
Feb-02-17 11:33AM  Acasti Pharma Announces Proposed Private Placement of Convertible Debentures and Amended Proposed Offering of Units Marketwired
Jan-18-17 11:23AM  Neptune Technologies & Bioresources, Inc. :NEPT-US: Earnings Analysis: Q3, 2017 By the Numbers : January 18, 2017 Capital Cube
Jan-12-17 05:16PM  Neptune Tech posts 3Q profit Associated Press
05:15PM  Acasti Pharma Reports Third Quarter 2017 Financial Results Marketwired
05:00PM  Neptune Announces Record Third Quarter Results Marketwired
Neptune Wellness Solutions Inc., a nutrition products company, produces and commercializes nutraceutical products and turnkey solutions primarily for omega-3 softgel capsules and liquids. It offers specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils, as well as pet supplements. The company's custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Technologies & Bioressources Inc. has an agreement with Tetra Bio-Pharma Inc. for the co-development, commercialization, and marketing of purified cannabinoid oil-based products to address pain and inflammation relief applications for the natural health products and pet veterinary markets. The company was founded in 1925 and is headquartered in Laval, Canada.